Mankind Pharma Ltd (MANKIND) — Cash Flow Reinvestment Rate
Latest as of December 2023:
0.00x
Mankind Pharma Ltd (MANKIND) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs2.19 Billion. Explore MANKIND capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Rs0.00
Capex + Investments
Operating Cash Flow
Rs2.19 Billion
INR
Capital Expenditures
Rs0.00
INR
Mankind Pharma Ltd Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Mankind Pharma Ltd across 7 annual periods. Also explore MANKIND asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Mankind Pharma Ltd (2019–2025)
Year-by-year capital reinvestment analysis for Mankind Pharma Ltd. For live market cap and broader valuation context, see Mankind Pharma Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | Rs4.61 Billion | Rs24.13 Billion | Rs4.61 Billion | ▲ +7.5% |
| 2024 | 0.18x | Rs3.82 Billion | Rs21.52 Billion | Rs3.82 Billion | ▼ -61.3% |
| 2023 | 0.46x | Rs8.32 Billion | Rs18.13 Billion | Rs8.32 Billion | ▼ -88.6% |
| 2022 | 4.04x | Rs37.15 Billion | Rs9.20 Billion | Rs23.46 Billion | ▲ +199.3% |
| 2021 | 1.35x | Rs15.35 Billion | Rs11.37 Billion | Rs3.12 Billion | ▲ +116.4% |
| 2020 | 0.62x | Rs6.67 Billion | Rs10.70 Billion | Rs2.28 Billion | ▲ +25.8% |
| 2019 | 0.50x | Rs2.98 Billion | Rs6.00 Billion | Rs2.98 Billion | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow